MedTrace Logo

Proactive Outreach for Smoking Treatment

NCT04988477 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2025-12-08

Study results available
· View outcomes & findings →

Summary

Tobacco use disorder is a chronic disease. This is particularly true for people living with mental illness, who are more likely to smoke and make more unsuccessful quit attempts than those without. The current study is designed to test a package of two chronic disease management strategies to treatment tobacco in community mental health centers: regular provider interventions during routine mental healthcare visits, and proactive outreach by community mental health center staff to offer connections to tobacco cessation treatment. In study 1 we will interview patients, providers and leaders across wo community healthcare systems, in study 2 we will pilot test the package of interventions in 25 patients at a community mental health center for feasibility and acceptability. in Study 3, 50 patients at a community mental health center will receive provider intervention at their regular visits as well as 3 outreach calls over 9 months from trained staff to offer to connect them with stop smoking treatment. The investigators will measure the effect of these interventions on tobacco use over the next year.

Conditions

  • Smoking, Tobacco
  • Mental Illness

Interventions

BEHAVIORAL

Study 3: Chronic care management

Quarterly brief provider intervention (the 5As) and 3 quarterly outreach calls over 9 months.

BEHAVIORAL

Study 2: Pilot trial

Providers trained in brief provider intervention and 1 outreach call over 3 months.

Sponsors & Collaborators

  • Brown University

    collaborator OTHER

  • University of Minnesota

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Sandra Japuntich

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-14
Primary Completion
2022-12-06
Completion
2023-01-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04988477 on ClinicalTrials.gov